featured
Interplay Between Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American College of Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure: EMPEROR-Reduced
J Am Coll Cardiol 2021 Mar 23;77(11)1397-1407, JP Ferreira, F Zannad, SJ Pocock, SD Anker, J Butler, G Filippatos, M Brueckmann, W Jamal, D Steubl, E Schueler, M PackerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.